For citations:
Liana P, Hafy Z, Oktariana D, Waruwu YP, Djamili PY, Umar TP. Hematologic profile of stage IIIB breast cancer patients receiving doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide regimens: An observational pilot study. Meditsinskiy sovet = Medical Council. 2026;(10):86-92. https://doi.org/10.21518/ms2026-226
JATS XML
































